Alan secures €480 million in funding, with Prosus leading the round at a valuation of €5.5 billion.

      French insurtech Alan has secured €480M in funding led by Prosus, achieving a valuation of €5.5bn, just months after its previous funding round. The Paris-based company aims to leverage AI-driven prevention to transform the health insurance landscape.

      Alan has raised €480M ($550M), valuing the company at €5.5bn ($6.3bn). The funding round, one of Europe’s largest non-AI-related raises this year, was led by Dutch investor Prosus. Existing investors, including Teachers’ Venture Growth and Index Ventures, participated, along with newcomer Dara Holdings. The round is still pending regulatory approval, including from France’s financial authorities, as insurance deals do not typically conclude in the same manner as pure software firms.

      What sets this round apart is its speed. Just three months prior, Alan raised €100M at a €5bn valuation. This latest funding increases that valuation by €500M and brings its total funding to over €1.2bn. It is uncommon for European startups to secure two rounds within a single quarter.

      Alan describes its business model as “prevention insurance,” integrating health coverage, care navigation, wellness services, and AI health support within a single application. The concept focuses on proactive measures to prevent illness rather than responding to it after the fact.

      Founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, Alan asserts that the current healthcare system operates on a reactive basis: waiting for lengthy appointment schedules, worsening symptoms, and coverage that only takes effect after illness occurs. Alan aims to shift this paradigm.

      “Health can’t wait—neither for symptoms to worsen, nor for an appointment to be scheduled months out, nor for the system to catch up,” stated co-founder and CEO Samuelian-Werve. “We believe that great health is a fundamental right, and that prevention should be equally accessible.”

      For the past decade, Alan has maintained that technology can enable proactive healthcare. Starting as a digital insurer, it has progressively added services. The term "prevention insurance" is its effort to categorize its comprehensive offerings rather than merely producing an improved policy.

      In practical terms, members benefit from quick reimbursements, accessible doctors via the app, and support available seven days a week. Alan is regulated by France's ACPR and operates as an independent insurer, rather than a broker.

      Alan's strong foundation underpins this new round of funding. In the first quarter of 2026, the company surpassed €800M in annual recurring revenue, marking a year-on-year growth of 53%. It serves over 1.1 million members and is profitable in France.

      This profitability is significant. Many insurtech firms endure years of losses, making steady profitability a rare achievement in the sector. Alan also operates in Spain, Belgium, and Canada and counts over 37,000 businesses among its clients, while employing more than 850 personnel. Customer satisfaction ratings are over 4.2 out of 5.

      Alan's client base is diverse; in addition to those 37,000 businesses, the company also serves self-employed individuals and retirees, groups that traditional insurers often overlook. This diversity equips Alan with valuable data across age and income demographics, which serve as essential inputs for its AI systems to identify risks early.

      The business model is intentionally capital-intensive, given that insurance requires reserves and market expansion necessitates additional capital. Alan's profitability in its home market provides a buffer that is often lacking for pure-growth competitors.

      The choice of Prosus as the lead investor is noteworthy. Prosus, the investment arm of South Africa’s Naspers, is recognized for its substantial stake in Tencent and a series of consumer platform acquisitions, including the €4.1 billion purchase of Just Eat Takeaway and the $1.8 billion deal for Stack Overflow.

      This background is significant because Prosus offers a broad network and extensive experience in scaling consumer products, capabilities that Alan requires to expand beyond the French market.

      “Healthcare represents one of the most substantial global opportunities for AI-led transformation,” noted Fahd Beg, head of investments at Prosus Group, commending Alan's “integrated platform where insurance, prevention, and care delivery complement each other.”

      Prosus is also developing AI tools across its various ventures and recently introduced ToqanClaw, an agent builder aimed at the roughly five million merchants within its network. Integrating Alan into this ecosystem could provide the insurer with established distribution channels in markets where it lacks recognition.

      AI is central to Alan's strategy. The company envisions that AI can deliver personalized prevention, navigation, and support to everyone, not just the affluent. Combined with its insurance platform, Alan hopes to enhance health outcomes while reducing long-term care costs.

      This belief is shared by many in the sector. A broader European initiative is redefining healthcare to focus on early detection instead of late treatment. For instance, Neko Health, a body-scanning startup established by Spotify’s Daniel